New Developments in Myeloma, An Issue of Hematology/Oncology Clinics of North America: The Clinics: Internal Medicine, cartea 38-2
Editat de Peter Leif Bergsagelen Limba Engleză Hardback – 29 feb 2024
Din seria The Clinics: Internal Medicine
- 5% Preț: 546.14 lei
- 5% Preț: 591.22 lei
- 5% Preț: 403.22 lei
- 5% Preț: 547.09 lei
- 5% Preț: 547.44 lei
- 5% Preț: 518.41 lei
- 5% Preț: 518.62 lei
- 5% Preț: 518.67 lei
- 5% Preț: 518.96 lei
- 5% Preț: 519.44 lei
- 5% Preț: 517.98 lei
- 5% Preț: 519.60 lei
- 5% Preț: 573.62 lei
- 5% Preț: 403.11 lei
- 5% Preț: 402.77 lei
- 5% Preț: 282.65 lei
- 5% Preț: 403.05 lei
- 5% Preț: 402.97 lei
- 5% Preț: 388.01 lei
- 5% Preț: 463.34 lei
- 5% Preț: 403.45 lei
- 5% Preț: 460.60 lei
- 5% Preț: 405.53 lei
- 5% Preț: 402.77 lei
- 5% Preț: 460.69 lei
- 5% Preț: 462.57 lei
- 5% Preț: 295.31 lei
- 5% Preț: 448.61 lei
- 5% Preț: 506.70 lei
- 5% Preț: 402.08 lei
- 5% Preț: 402.52 lei
- 5% Preț: 402.52 lei
- 5% Preț: 519.15 lei
- 5% Preț: 518.39 lei
- 5% Preț: 603.73 lei
- 5% Preț: 518.21 lei
- 5% Preț: 518.09 lei
- 21% Preț: 450.00 lei
- 21% Preț: 448.67 lei
- 5% Preț: 576.44 lei
- 5% Preț: 576.17 lei
- 5% Preț: 577.92 lei
- 5% Preț: 576.94 lei
- 5% Preț: 570.07 lei
- 5% Preț: 576.11 lei
- 5% Preț: 686.25 lei
- 5% Preț: 547.43 lei
- 5% Preț: 764.42 lei
- 5% Preț: 576.27 lei
- 5% Preț: 579.22 lei
Preț: 636.49 lei
Preț vechi: 669.98 lei
-5% Nou
Puncte Express: 955
Preț estimativ în valută:
121.85€ • 125.31$ • 101.09£
121.85€ • 125.31$ • 101.09£
Carte disponibilă
Livrare economică 29 ianuarie-12 februarie
Livrare express 14-18 ianuarie pentru 40.68 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443130779
ISBN-10: 0443130779
Pagini: 240
Dimensiuni: 152 x 229 x 20 mm
Greutate: 0.62 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0443130779
Pagini: 240
Dimensiuni: 152 x 229 x 20 mm
Greutate: 0.62 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Molecular Pathogenesis of Multiple Myeloma: Clinical Implications
Immune-Pathogenesis of Myeloma
Smoldering Multiple Myeloma: Observation Versus Control Versus Cure
Cereblon-targeting ligase degraders in myeloma: Mechanisms of action and resistance
Proteasome Inhibitors in Multiple Myeloma: Biological Insights on Mechanisms of Action or Resistance Informed by Functional Genomics
Monoclonal Antibodies in the Treatment of Multiple Myeloma
Bispecific Antibodies in the Treatment of Multiple Myeloma
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma
Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?
Role of Consolidation and Maintenance
Management of Newly Diagnosed Multiple Myeloma Today, and in the Future
Impact of Clonal Heterogeneity in Multiple Myeloma
Measurable Residual Disease and Decision-Making in Multiple Myeloma
Approach to High-Risk Multiple Myeloma
New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma
Immunocompetent Mouse Models of Multiple Myeloma: Therapeutic Implications
Immune-Pathogenesis of Myeloma
Smoldering Multiple Myeloma: Observation Versus Control Versus Cure
Cereblon-targeting ligase degraders in myeloma: Mechanisms of action and resistance
Proteasome Inhibitors in Multiple Myeloma: Biological Insights on Mechanisms of Action or Resistance Informed by Functional Genomics
Monoclonal Antibodies in the Treatment of Multiple Myeloma
Bispecific Antibodies in the Treatment of Multiple Myeloma
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma
Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?
Role of Consolidation and Maintenance
Management of Newly Diagnosed Multiple Myeloma Today, and in the Future
Impact of Clonal Heterogeneity in Multiple Myeloma
Measurable Residual Disease and Decision-Making in Multiple Myeloma
Approach to High-Risk Multiple Myeloma
New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma
Immunocompetent Mouse Models of Multiple Myeloma: Therapeutic Implications